Title21 Health Solutions Acquires cResults
Scottsdale, AZ — June 2, 2026 · KMAK Capital
Title21 Health Solutions has acquired cResults, a provider of efficiency management, resource planning, and scheduling solutions for quality operations in life sciences. The announcement comes about five months after Title21’s acquisition of MyCellHub.
cResults provides SaaS-based digital performance platforms for QC and QA laboratories. Its Smart-QX platforms target cycle time, on-time delivery, and resource efficiency. The company also offers Smart-FDA for compliance analysis and Smart-AID for batch record review automation.
“For years, our clients have requested smarter tools for planning and scheduling their quality operations, tools that connect seamlessly with their quality management systems and give them real visibility into resource capacity and workload.”
Per the announcement, life sciences organizations managing multiple products, sites, and regulatory requirements have faced bottlenecks from a lack of specialized scheduling tools. Integrating cResults into Title21’s portfolio is intended to combine quality management with resource planning and scheduling in one solution.